SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS/A - Annual Report to Security Holders: [Amend]
SEC Accession No. 0000950170-24-059743
Filing Date
2024-05-14
Accepted
2024-05-14 16:58:19
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-14

Document Format Files

Seq Description Document Type Size
1 ARS/A evoke-_arsa_restate.pdf ARS/A 1046508
  Complete submission text file 0000950170-24-059743.txt   1442582
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS/A | Act: 34 | File No.: 001-36075 | Film No.: 24945449
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)